News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioIndustry Association Release: Chancellor Confirms Biomedical Catalyst Scheme to Continue


6/25/2013 10:26:12 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

25 June 2013 -- The BioIndustry Association (BIA) welcomes the Chancellor of the Exchequer's response to George Freeman's Treasury Question on the Biomedical Catalyst.

Speaking in the House of Commons, the Chancellor said:

"The Biomedical Catalyst fund has been very successful at supporting small businesses in this sector. Without giving too much away about tomorrow, I can tell him that we will go on funding this scheme."

Steve Bates, BIA Chief Executive Officer, said:

"The BIA is delighted the Chancellor has committed to continuing to fund the Biomedical Catalyst and recognises the value of investing in UK bioscience companies. I would like to thank all our members for making such a convincing case and look forward to hearing further details in the next few days."

For further information, please contact Robert Winder, Head of Communications, rwinder@bioindustry.org, 020 7630 2191; mobile 07825 942 934.

Parliamentary question

George Freeman's parliamentary question and the chancellor's response is available on Parliament TV

http://bit.ly/11XJGgR at 11.45 am

BIA Biomedical Catalyst report

http://bit.ly/BIA_bmcreport

BIA Biomedical Catalyst campaign

The BIA has led the campaign for the government to re-fill the Biomedical Catalyst http://bit.ly/11Rp3DU

BioIndustry Association

Founded over 20 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector. The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives. For further information, please go to www.bioindustry.org

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES